Castleark Management’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-71,390
Closed -$5.97M 304
2023
Q2
$5.97M Buy
71,390
+20,560
+40% +$1.67M 0.27% 85
2023
Q1
$3.76M Buy
+50,830
New +$3.57M 0.18% 123
2020
Q4
Sell
-95,783
Closed -$4.17M 353
2020
Q3
$4.17M Sell
95,783
-95,892
-50% -$4.33M 0.16% 136
2020
Q2
$8.75M Buy
191,675
+62,855
+49% +$2.54M 0.38% 62
2020
Q1
$4.03M Buy
+128,820
New +$4.59M 0.24% 118
2019
Q2
Sell
-186,443
Closed -$11.5M 376
2019
Q1
$11.5M Sell
186,443
-3,468
-2% -$197K 0.43% 64
2018
Q4
$10.6M Sell
189,911
-100,455
-35% -$5.97M 0.45% 58
2018
Q3
$17.8M Buy
290,366
+125,961
+77% +$7.24M 0.51% 52
2018
Q2
$8.42M Buy
+164,405
New +$8.15M 0.26% 125

Other funds holding MMSI

Castleark Management's MMSI Position: Q3 2023 in Review

Castleark Management sold out of Merit Medical Systems (MMSI) in Q3 2023, closing a stake of 71,390 shares — an estimated $5.97M sold.

Castleark Management first reported a position in MMSI in Q2 2018 and held it in 9 quarters. The position peaked at $17.8M in Q3 2018. 272 funds tracked by Wall St. Rank hold MMSI as of Q3 2023.

  • Castleark Management reported no remaining Merit Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Castleark Management sold 71,390 Merit Medical Systems shares in Q3 2023, an estimated $5.97M.
  • Castleark Management first reported a position in Merit Medical Systems in Q2 2018 and held it in 9 quarters.
  • Castleark Management's Merit Medical Systems position peaked at $17.8M in Q3 2018.
  • 272 funds tracked by Wall St. Rank held Merit Medical Systems as of Q3 2023.

Based on Castleark Management's 13F filing for Q3 2023, filed 15 Nov 2023.